The North American Consortia for the Study of End Stage Liver Disease

Our Mission

Improve outcomes for inpatients and outpatients with cirrhosis across North America.

Why it Matters

Cirrhosis remains a major cause of morbidity and mortality across North
America but the determinants change over time.

All Consortia

ACTIVE

Started: June 2020

NACSELD 3

Multicenter cohort of outpatients
with cirrhosis with compensated
and decompensated cirrhosis

Started: October 2013

NACSELD 2

Multicenter cohort of patients
with cirrhosis hospitalized
non-electively

Started: November 2010

NACSELD 1

Multicenter cohort of inpatients
with cirrhosis with infections

Contact Us